SFP
SGMO

Sandbox Financial Partners’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Sandbox Financial Partners’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.13K Hold
24,833
– – ﹤0.01% 117
2025
Q4 		$10.4K Hold
24,833
– – ﹤0.01% 123
2025
Q3 		$16.7K Hold
24,833
– – ﹤0.01% 128
2025
Q2 		$13.4K Hold
24,833
– – ﹤0.01% 123
2025
Q1 		$16.3K Hold
24,833
– – 0.01% 108
2024
Q4 		$25.3K Hold
24,833
– – 0.01% 107
2024
Q3 		$21.5K Hold
24,833
– – 0.01% 108
2024
Q2 		$8.9K Hold
24,833
– – ﹤0.01% 97
2024
Q1 		$16.6K Hold
24,833
– – 0.01% 97
2023
Q4 		$13.5K Buy
+24,833
New +$11.4K 0.01% 88
2023
Q3 		– Sell
-24,833
Closed -$32.3K – 94
2023
Q2 		$32.3K Hold
24,833
– – 0.02% 93
2023
Q1 		$43.7K Hold
24,833
– – 0.03% 88
2022
Q4 		$78K Hold
24,833
– – 0.05% 86
2022
Q3 		$122K Hold
24,833
– – 0.09% 80
2022
Q2 		$103K Hold
24,833
– – 0.07% 83
2022
Q1 		$144K Buy
+24,833
New +$148K 0.08% 91

Other funds holding SGMO

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Sandbox Financial Partners's SGMO Position: Q1 2026 in Review

Sandbox Financial Partners held its SANGAMO THERAPEUTICS INC (SGMO) position steady in Q1 2026 at 24,833 shares worth $6.13K. The position accounts for ﹤0.01% of the portfolio, ranked #117.

Sandbox Financial Partners first reported a position in SGMO in Q1 2022 and has held it in 16 quarters since. The position peaked at $144K in Q1 2022. 112 funds tracked by Wall St. Rank hold SGMO as of Q1 2026.

  • Sandbox Financial Partners held 24,833 shares of SANGAMO THERAPEUTICS INC worth $6.13K as of Q1 2026.
  • Sandbox Financial Partners left its SANGAMO THERAPEUTICS INC share count unchanged in Q1 2026.
  • SANGAMO THERAPEUTICS INC made up ﹤0.01% of Sandbox Financial Partners's portfolio in Q1 2026, its #117 holding.
  • Sandbox Financial Partners first reported a position in SANGAMO THERAPEUTICS INC in Q1 2022 and has held it in 16 quarters since.
  • Sandbox Financial Partners's SANGAMO THERAPEUTICS INC position peaked at $144K in Q1 2022.
  • 112 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2026.

Based on Sandbox Financial Partners's 13F filing for Q1 2026, filed 8 Apr 2026.